Brief: Vicore Pharma Holding Q3 Operating Loss Narrows To SEK 69.7 Mln
03/11/2022 07:19
Nov 3 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* INTERIM REPORT JULY-SEPTEMBER 2022
* Q3 OPERATING LOSS WAS -69.7 MSEK (-97.8)
Source text for Eikon: ID:nWkr3GkhV3
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2